• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Mark Pomerantz, MD

Publications

  • Nakabayashi M, Hayes J, Taplin ME, Lefebvre P, Lafeuille MH, Pomerantz M, Sweeney C, Duh MS, Kantoff PW.Clinical predictors of survival in men with castration-resistant prostate cancer: Evidence That Gleason Score 6 Cancer Can Evolve to Lethal Disease.Cancer. 2013 Aug 15;119(16):2990-8.
    23719969
  • Pomerantz M, Freedman ML.Clinical uncertainty of prostate cancer genetic risk panels.Sci Transl Med. 2013 Apr 24;5(182):182ed6.
    23616119
  • Schutz FA, Pomerantz MM, Gray KP, Atkins MB, Rosenberg JE, Hirsch MS, McDermott DF, Lampron ME, Lee GS, Signoretti S, Kantoff PW, Freedman ML, Choueiri TK.Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study.Lancet Oncol. 2013 Jan;14(1):81-7.
    23219378
  • Van Allen EM, Pomerantz M.Moving toward personalized medicine in castration-resistant prostate cancer.Urol Clin North Am. 2012 Nov;39(4):483-90. Review.
    23084525
  • Grisanzio C, Werner L, Takeda D, Awoyemi BC, Pomerantz MM, Yamada H, Sooriakumaran P, Robinson BD, Leung R, Schinzel AC, Mills I, Ross-Adams H, Neal DE, Kido M, Yamamoto T, Petrozziello G, Stack EC, Lis R, Kantoff PW, Loda M, Sartor O, Egawa S, Tewari AK, Hahn WC, Freedman ML.Genetic and functional analyses implicate the NUDT11, HNF1B, and SLC22A3 genes in prostate cancer pathogenesis.Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11252-7.
    22730461
  • Pomerantz M, Werner L, Xie W, Regan MM, Lee GS, Sun T, Evan C, Petrozziello G, Nakabayashi M, Oh WK, Kantoff PW, Freedman ML.Association of prostate cancer risk loci with disease aggressiveness and prostate cancer-specific mortality.Cancer Prev Res (Phila Pa). 2011 Mar 2.
    21367958
  • Pomerantz MM, Shrestha Y, Flavin RJ, Regan MM, Penney KL, Mucci LA, Stampfer MJ, Hunter DJ, Chanock SJ, Schafer EJ, Chan JA, Tabernero J, Baselga J, Richardson AL, Loda M, Oh WK, Kantoff PW, Hahn WC, Freedman ML.Analysis of the 10q11 cancer risk locus implicates MSMB and NCOA4 in human prostate tumorigenesis.PLoS Genet. 2010;6(11):e1001204.
    21085629
  • Ahmadiyeh N, Pomerantz MM, Grisanzio C, Herman P, Jia L, Almendro V, He HH, Brown M, Liu XS, Davis M, Caswell JL, Beckwith CA, Hills A, Macconaill L, Coetzee GA, Regan MM, Freedman ML.8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC.Proc Natl Acad Sci U S A. 2010 May 25;107(21):9742-6.
    20453196
  • Whitman EJ, Pomerantz M, Chen Y, Chamberlin MM, Furusato B, Gao C, Ali A, Ravindranath L, Dobi A, Sesterhenn IA, Sestrehenn IA, McLeod DG, Srivastava S, Freedman M, Petrovics G.Prostate cancer risk allele specific for African descent associates with pathologic stage at prostatectomy.Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):1-8.
    20056617
  • Jia L, Landan G, Pomerantz M, Jaschek R, Herman P, Reich D, Yan C, Khalid O, Kantoff P, Oh W, Manak JR, Berman BP, Henderson BE, Frenkel B, Haiman CA, Freedman M, Tanay A, Coetzee GA.Functional enhancers at the gene-poor 8q24 cancer-linked locus.PLoS Genet. 2009 Aug;5(8):e1000597.
    19680443
  • Pomerantz MM, Ahmadiyeh N, Jia L, Herman P, Verzi MP, Doddapaneni H, Beckwith CA, Chan JA, Hills A, Davis M, Yao K, Kehoe SM, Lenz HJ, Haiman CA, Yan C, Henderson BE, Frenkel B, Barretina J, Bass A, Tabernero J, Baselga J, Regan MM, Manak JR, Shivdasani R, Coetzee GA, Freedman ML.The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer.Nat Genet. 2009 Aug;41(8):882-4.
    19561607
  • Pomerantz MM, Beckwith CA, Regan MM, Wyman SK, Petrovics G, Chen Y, Hawksworth DJ, Schumacher FR, Mucci L, Penney KL, Stampfer MJ, Chan JA, Ardlie KG, Fritz BR, Parkin RK, Lin DW, Dyke M, Herman P, Lee S, Oh WK, Kantoff PW, Tewari M, McLeod DG, Srivastava S, Freedman ML.Evaluation of the 8q24 prostate cancer risk locus and MYC expression.Cancer Res. 2009 Jul 1;69(13):5568-74.
    19549893